- Home
- PZZA vs BCRX Comparison
PZZA vs BCRX Comparison
Compare PZZA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PZZA | BCRX |
|---|---|---|
| Founded | 1984 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 1993 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PZZA | BCRX |
|---|---|---|
| Price | $41.50 | $7.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $49.44 | $19.00 |
| AVG Volume (30 Days) | 765.6K | ★ 3.9M |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | ★ 4.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $2,086,399,000.00 | $599,816,000.00 |
| Revenue This Year | $2.60 | $40.20 |
| Revenue Next Year | N/A | $7.71 |
| P/E Ratio | $36.38 | ★ N/A |
| Revenue Growth | N/A | ★ 45.38 |
| 52 Week Low | $30.16 | $6.00 |
| 52 Week High | $55.74 | $11.31 |
Technical Indicators
Market Signals| Indicator | PZZA | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 58.81 |
| Support Level | $40.53 | $7.23 |
| Resistance Level | $42.77 | $7.98 |
| Average True Range (ATR) | 1.23 | 0.34 |
| MACD | 0.28 | 0.03 |
| Stochastic Oscillator | 28.61 | 63.48 |
Price Performance
Historical ComparisonAbout PZZA Papa John's International Inc.
Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.